This week's Barrons features Alzheimer's, Is Hope Near?" "Big pharmaceutical companies have struggled for years to develop a drug that will halt the progression of Alzheimer's disease, a terrible neurological ailment that begins with memory loss and steadily robs patients of brain function, leading to dementia and death. Success would have an enormous societal impact and help to contain the cost of an ever-increasing population of Alzheimer's patients, which number an estimated five million in the U.S. -- and 26 million worldwide."
Click here to read more.
After reading this....we can now ask why India has the lowest rate of Alzheimer's disease. Find out why later.
Have a blissful day!
No comments:
Post a Comment